Octave Specialty Group (OSG)
Builds specialty insurance businesses through underwriting capacity and niche MGA distribution.
OSG Q2 Earnings Miss Estimates, Revenues Beat on Distribution Growth
OSG's Q2 revenues jumped 51% on strong Insurance Distribution growth and improving Everspan results, prompting a higher 2026 distribution outlook.
OSG Q2 Earnings Call Focuses on MGA Growth and Mixed Guidance
Octave Specialty Group raises 2026 Distribution growth and EBITDA guidance as MGA momentum accelerates, while cutting EPS and Everspan outlooks.
Octave Specialty Group Q2 Earnings Call Highlights
Octave Specialty Group NYSE: OSG reported improved second-quarter results as growth in its Insurance Distribution segment and progress at its Everspan specialty insurance platform narrowed its net loss and lifted adjusted EBITDA.
Octave Specialty Group, Inc. (OSG) Q2 2026 Earnings Call Transcript
Octave Specialty Group, Inc. (OSG) Q2 2026 Earnings Call Transcript
Octave Specialty Group (OSG) Reports Q2 Loss, Beats Revenue Estimates
Octave Specialty Group (OSG) came out with a quarterly loss of $0.04 per share versus the Zacks Consensus Estimate of a loss of $0.01. This compares to a loss of $0.22 per share a year ago.
Octave Specialty Group to Report Q2 Earnings: What to Expect
Octave Specialty heads into Q2 results with revenues projected to jump 47.4%. The bottom line is likely to improve y/y, though the model does not signal a beat.
Octave Specialty (OSG) Soars 8.5%: Is Further Upside Left in the Stock?
Octave Specialty (OSG) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Octave Specialty (OSG) Upgraded to Strong Buy: Here's Why
Octave Specialty (OSG) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
3 Reasons Why Octave Specialty (OSG) Is a Great Growth Stock
Octave Specialty (OSG) possesses solid growth attributes, which could help it handily outperform the market.
Octave Specialty Group Q1 Earnings Call Highlights
Octave Specialty Group NYSE: OSG reported a narrower first-quarter loss and sharply higher adjusted earnings, driven by rapid growth in its insurance distribution business and contributions from its recent ArmadaCare acquisition.
Octave Specialty Group, Inc. (OSG) Q1 2026 Earnings Call Transcript
Octave Specialty Group, Inc. (OSG) Q1 2026 Earnings Call Transcript
Octave Specialty Group Reports First Quarter 2026 Results
NEW YORK--(BUSINESS WIRE)--Octave Specialty Group Reports First Quarter 2026 Results.
Octave Specialty Group to Release First Quarter 2026 Results on May 6, 2026
NEW YORK--(BUSINESS WIRE)--Octave Specialty Group to Release First Quarter 2026 Results on May 6, 2026.
Octave Specialty Group Announces Meeting and Record Date for 2026 Annual Meeting of Stockholders
NEW YORK--(BUSINESS WIRE)--Octave Specialty Group Announces Meeting and Record Date for 2026 Annual Meeting of Stockholders.
Down 15.5% in 4 Weeks, Here's Why Octave Specialty (OSG) Looks Ripe for a Turnaround
The heavy selling pressure might have exhausted for Octave Specialty (OSG) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
Octave Specialty (OSG) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
Octave Specialty (OSG) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.
Octave Specialty Group, Inc. (OSG) Q4 2025 Earnings Call Transcript
Octave Specialty Group, Inc. (OSG) Q4 2025 Earnings Call Transcript
Octave Specialty Group (OSG) Reports Q4 Loss, Misses Revenue Estimates
Octave Specialty Group (OSG) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of a loss of $0.21. This compares to a loss of $0.12 per share a year ago.
Octave Specialty Group Reports Fourth Quarter 2025 Results
NEW YORK--(BUSINESS WIRE)--Octave Specialty Group Reports Fourth Quarter 2025 Results.
Hammurabi, a Division of Xchange Benefits, Unveils AI Platform That Revolutionizes Medical Stop Loss Underwriting
ARMONK, N.Y.--(BUSINESS WIRE)--Hammurabi, a Division of Xchange Benefits, Unveils AI Platform That Revolutionizes Medical Stop Loss Underwriting.